biopharmaceutical production
biopharmaceutical production
Sandoz Acquires Lucentis for $170 Million Boosting Ophthalmology Portfolio and Expanding Global Access
📰 Sandoz acquires Coherus' Lucentis for $170m, expanding its ophthalmology portfolio. 💰 Lucentis treats eye diseases worldwide.
Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech
📢 Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. 💼🌐💪📈
Pharma’s Tech Revolution: AI and Synbio Supercharge Biologics
📰 Pharma is using new technologies like AI and synthetic biology to maximize biologics manufacturing. 💊 Innovations are improving antibody stability and yield, accelerating production and drug development. 🌐
Unlocking Biopharma’s Full Potential with IoT
📢 Biopharma industry lags in embracing IoT due to complexity. 🔬 IoT can enhance processes, cut costs. 🏭 Challenges exist. 💡 Sector-wide effort needed. 🌐 Universal solutions, strategies, training can help.
Time-saving Raman Spectroscopy Models for Cell Culture Monitoring
🔍 Raman spectroscopy is becoming popular for monitoring cell cultures in biopharmaceutical production. 🔬 Creating accurate calibration models for Raman-based monitoring is challenging and time-consuming. 🧪 Scientists developed orthogonal projection to latent structures (OPLS) models to predict production and culture indicators. 📊 The models accurately predicted glucose and lactate levels across different clones, but had issues with predicting titer levels. ✨ A generic calibration model can be used for glucose and lactate levels, but not for product prediction. 🔬 Raman spectroscopy is useful for monitoring cell cultures, but creating calibration models is still time-consuming.
